ByTrending Posts
NVIDIA and GE HealthCare Join Forces to Accelerate…
Key Highlights: GTC, Santa Clara, CA — NVIDIA and GE HealthCare today announced a strategic collaboration to develop…
Pfizer and Data4Cure Collaborate to Advance AI-Driven Drug…
March 16, 2025 — Santa Clara, CAAt the 2025 Precision Medicine World Conference (PMWC), experts from Pfizer and…
AION Labs and BioMed X Launch Global 2025…
Backed by AstraZeneca, Merck, Pfizer, Teva, AWS, and top venture firms, the initiative seeks global innovators to build…
Stroke Care AI: How Are Medtronic and Brainomix…
Medtronic and Brainomix Join Forces to Deliver Faster, Smarter Stroke Care with AI-Powered Imaging February 27, 2025 –…
BullFrog AI and Eleison Pharmaceuticals Collaborate to Optimize…
Gaithersburg, Md – Feb 27 2025 BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a leading AI-driven drug development…
Incyte and Genesis Therapeutics Forge AI-Driven Partnership to…
BURLINGAME, California – Feb 20, 2025 Accelerating Innovation with AI-Powered Drug Design Incyte (Nasdaq: INCY) and Genesis Therapeutics…
AI-Powered Insilico Medicine Doses First Patient in Phase…
Cambridge, Mass. — Jan 22, 2025 Insilico Medicine, a biotechnology company leveraging generative artificial intelligence (AI) for drug…
Insilico Medicine’s AI Platform Unveils GBP2 and HCK…
InSilico Medicine — Jan 15, 2025AI-Driven Research Unveils New Therapeutic Approaches Researchers have leveraged artificial intelligence to discover…
Can Yseop and Novartis Cut Drug Development Timelines…
Elite AI Partnership with NovartisYseop has been named among only seven elite AI partners by Novartis, aiming to…
Trending Posts
Latest Stories
Did Renal Therapy Approvals in 2025 Redefine Kidney Disease Management—and Set the Stage for Breakthroughs in 2026?
Global – December 2025 — The renal therapeutic area emerged as a renewed focus of…
Did Cardiovascular Approvals in 2025 Signal a New Era in Heart Disease Management—and Set the Pace for 2026 Innovation?
Global – December 2025 — The cardiovascular (CV) therapeutic area re-emerged as a strategic growth…
Did Infectious Disease Approvals in 2025 Redefine Global Preparedness—and Set the Course for Innovation in 2026?
Global – December 2025 — The infectious diseases (ID) landscape underwent a structural recalibration in…
Did Neuroscience Approvals in 2025 Mark a Turning Point—and Set the Stage for a Breakout Year in 2026?
Global – December 2025 — The neuroscience sector experienced a long-anticipated resurgence in 2025, driven…
Gallery
